Papers
1
Total Citations
8
H-Index
1
About
Hyemi Lee is a molecular biologist whose research centers on chemical genetics, drug target identification, and the mechanisms of natural product derivatives in model organisms. Her most cited work, a 2008 study on hydrazinocurcumin (HC)—a synthetic curcumin derivative with anti-angiogenic properties—employs a genome-wide drug-induced haploinsufficient screening approach in fission yeast to uncover the compound's molecular targets. This innovative methodology allowed Lee to systematically identify genes whose reduced dosage confers hypersensitivity to HC, revealing pathways critical to the drug's action. By elucidating these mechanisms, her research provides a foundation for developing improved curcumin-based compounds with enhanced pharmacological properties. Though her citation count for this seminal paper stands at 8, the work's significance lies in its methodological contribution to chemical genomics and its potential to guide rational drug design. Lee's approach exemplifies how model organism genetics can bridge natural product chemistry and therapeutic development, offering a powerful strategy for target deconvolution in complex biological systems. Her findings remain relevant for researchers exploring the molecular underpinnings of anti-angiogenic compounds and the broader utility of haploinsufficiency profiling in drug discovery.
Research Focus
Key Achievements
Top Papers
- 1